Mark Ratner. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Clinical Trials, Phase II as TopicCrohn Disease/economicsCrohn Disease/therapyDNA, Antisense/geneticsDNA, Antisense/therapeutic useDrug Industry/economicsGenetic Therapy/economicsHumansUnited States
Substances: See more » DNA, Antisense
Year: 2014 PMID: 25004213 DOI: 10.1038/nbt0714-605b
Source DB: PubMed Journal: Nat Biotechnol ISSN: 1087-0156 Impact factor: 54.908